The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer
- PMID: 36010256
- PMCID: PMC9406692
- DOI: 10.3390/diagnostics12081906
The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer
Abstract
The development of malignancy is closely connected with the process of cancer microenvironment remodeling. As a malignancy develops, it stimulates the creation of the suppressive microenvironment of the tumor through the presence of cells that express membrane proteins. These proteins are secreted into the cancer microenvironment, where they enable tumor growth. In patients with cancer of the cervix, the development of the disease is also linked to high-risk HPV (hr-HPV) infection. Such infections are common, and most clear spontaneously; however, a small percentage of these infections can persist and progress into precancerous cervical intraepithelial neoplasia and invasive cervical carcinoma. Consequently, it is assumed that the presence of hr-HPV infection alone is not sufficient for the development of cancer. However, chronic HPV infection is associated with the induction of the remodeling of the microenvironment of the epithelium. Furthermore, the local microenvironment is recognized as a cofactor that participates in the persistence of the HPV infection and disease progression. This review presents the selected immune evasion mechanisms responsible for the persistence of HPV infection, beginning with the delay in the virus replication process prior to the maturation of keratinocytes, the shift to the suppressive microenvironment by a change in keratinocyte immunomodulating properties, the alteration of the Th1/Th2 polarization of the immune response in the microenvironment, and, finally, the role of HLA-G antigen expression.
Keywords: HLA-G antigen expression; cervical cancer; suppressive cancer microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
HPV-Related Cervical Cancer and Extracellular Vesicles.Diagnostics (Basel). 2022 Oct 25;12(11):2584. doi: 10.3390/diagnostics12112584. Diagnostics (Basel). 2022. PMID: 36359429 Free PMC article. Review.
-
The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.Cytokine Growth Factor Rev. 2017 Apr;34:1-13. doi: 10.1016/j.cytogfr.2017.03.002. Epub 2017 Mar 23. Cytokine Growth Factor Rev. 2017. PMID: 28365229 Review.
-
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):807-13. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9332763
-
Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?Dis Esophagus. 2019 Jul 1;32(7):doz008. doi: 10.1093/dote/doz008. Dis Esophagus. 2019. PMID: 31304554 Review.
-
Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.J Obstet Gynaecol Res. 2007 Apr;33(2):103-13. doi: 10.1111/j.1447-0756.2007.00492.x. J Obstet Gynaecol Res. 2007. PMID: 17441881 Review.
Cited by
-
Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer.Front Oncol. 2024 Oct 18;14:1463445. doi: 10.3389/fonc.2024.1463445. eCollection 2024. Front Oncol. 2024. PMID: 39493451 Free PMC article.
-
HPV-Related Cervical Cancer and Extracellular Vesicles.Diagnostics (Basel). 2022 Oct 25;12(11):2584. doi: 10.3390/diagnostics12112584. Diagnostics (Basel). 2022. PMID: 36359429 Free PMC article. Review.
-
Traditional Chinese Medicine Erhuang Suppository for Treatment of Persistent High-risk Human Papillomavirus Infection and Its Impact on Transcriptome of Uterine Cervix.Curr Med Sci. 2024 Aug;44(4):841-853. doi: 10.1007/s11596-024-2898-7. Epub 2024 Jul 23. Curr Med Sci. 2024. PMID: 39039373 Clinical Trial.
-
Human Papillomavirus Carcinogenicity and the Need of New Perspectives: Thoughts from a Retrospective Analysis on Human Papillomavirus Outcomes Conducted at the Hospital University of Bari, Apulia, Italy, between 2011 and 2022.Diagnostics (Basel). 2024 May 6;14(9):968. doi: 10.3390/diagnostics14090968. Diagnostics (Basel). 2024. PMID: 38732382 Free PMC article.
-
Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment.Vaccines (Basel). 2023 Aug 11;11(8):1354. doi: 10.3390/vaccines11081354. Vaccines (Basel). 2023. PMID: 37631922 Free PMC article. Review.
References
-
- Walentowicz-Sadlecka M., Koper A., Galazka K., Koper K., Basta P., Mach P., Skret-Magierlo J., Dutsch-Wicherek M., Sikora J., Grabiec M., et al. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease. Am. J. Reprod. Immunol. 2013;70:253–261. doi: 10.1111/aji.12120. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials